Psychiatry News Roundup: Misconduct Probe, Telehealth for Addiction, and CBT for Gaming Disorder
A Connecticut psychiatrist faces 21 alleged violations including improper prescribing and inappropriate relationships. A new telehealth platform targets GLP-1 drugs for addiction, while a CDC report links cannabis to 21% of overdose deaths. A randomized trial shows cognitive behavioral therapy outperforms media literacy for gaming disorder.
The investigation into the Connecticut psychiatrist highlights concerns about prescribing practices and professional boundaries. Meanwhile, a new telehealth service explores using GLP-1 drugs for addiction, while CDC data shows cannabis present in a fifth of overdose deaths. Danish research indicates diagnostic profiles for ADHD and autism are becoming less distinct over time, and longer initial insomnia prescriptions correlate with sustained use years later.
On the treatment front, cognitive behavioral therapy proved more effective than media literacy for adolescent gaming disorder. Long-acting injectable antipsychotics reduced bipolar relapse rates compared to oral pills. Additionally, a review found nearly 20% of pediatric psychiatric crises involved digital devices, and combining psychological support with medication eased pre-surgery anxiety in older adults.
This roundup suggests several shifts in mental health care. The misconduct probe could erode patient trust in psychiatry, while the telehealth platform may expand addiction treatment access but raises questions about off-label prescribing. The CDC's cannabis-overdose link could inform public health warnings. CBT's success for gaming disorder may guide school-based interventions, and the high rate of digital-related pediatric crises could prompt families to reassess screen time. These developments may collectively influence clinical guidelines and patient expectations.